Skye Bioscience, Inc. (SKYE)
2025-06-30 | ||||
|---|---|---|---|---|
| Provision for income taxes | 3,400 | |||
| Research and development | 14,337,753 | |||
| General and administrative | 3,906,172 | |||
| Total operating expenses | 18,243,925 | |||
| Operating loss | -18,243,925 | |||
| Other expense | - | |||
| Interest and other income, net | 533,090 | |||
| Interest expense | - | |||
| Gain on sale of asset | 89,363 | |||
| Total other (income) expense, net | 622,453 | |||
| Loss before income taxes | -17,621,472 | |||
| Net loss | -17,624,872 | |||
| Basic (in dollars per share) | -0.44 | |||
| Basic (in shares) | 39,659,266 | |||
| Diluted (in dollars per share) | -0.44 | |||
| Diluted (in shares) | 39,659,266 | |||